{"id":10569,"date":"2026-03-12T09:50:04","date_gmt":"2026-03-12T13:50:04","guid":{"rendered":"https:\/\/www.rigicon.com\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/"},"modified":"2026-03-12T09:50:04","modified_gmt":"2026-03-12T13:50:04","slug":"first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es","status":"publish","type":"clinical-evidence","link":"https:\/\/www.rigicon.com\/es\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/","title":{"rendered":"Primeros resultados de seguridad del esf\u00ednter urinario artificial ContiReflex\u00ae para el tratamiento de la incontinencia masculina"},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","tags":[],"ce_category":[235],"ce_product":[265],"class_list":["post-10569","clinical-evidence","type-clinical-evidence","status-publish","hentry","ce_category-posteres-y-resumenes-es","ce_product-contireflex-es"],"acf":{"ce_paper_title":"","ce_year":2024,"ce_journal":"The Journal of Urology","ce_doi":"https:\/\/www.auajournals.org\/doi\/10.1097\/01.JU.0001009488.55564.85.16","ce_summary":"Un an\u00e1lisis multic\u00e9ntrico de 50 pacientes mostr\u00f3 que el AUS ContiReflex\u00ae es seguro y eficaz, sin infecciones, sin erosiones y con una supervivencia del dispositivo del 98% a los 18 meses.","ce_authors":"Steven K. Wilson, Eric Chung, Brian Langford, Rowland Rees, Dominic Lee, Ricardo Schlessinger, George Koufogiannis, Daniel Moon, Koenraad Van Renterghem","ce_objective":"<p class=\"ai-optimize-6\">Evaluar el perfil de seguridad temprano y los resultados quir\u00fargicos del esf\u00ednter urinario artificial Rigicon ContiReflex<sup>\u00ae<\/sup> en el tratamiento de la incontinencia de esfuerzo masculina.<\/p>","ce_key_findings":"<p class=\"ai-optimize-7\">Entre 50 pacientes, no se produjeron infecciones ni erosiones. Se requiri\u00f3 una revisi\u00f3n (2%). Un an\u00e1lisis de Kaplan-Meier mostr\u00f3 una supervivencia del dispositivo del 98% a los 18 meses.<\/p>","ce_conclusion":"<p class=\"ai-optimize-8\">El AUS Rigicon ContiReflex<sup>\u00ae<\/sup> demuestra un perfil de seguridad temprano favorable y es comparable a los dispositivos de esf\u00ednter existentes en el tratamiento de la incontinencia masculina.<\/p>","ce_clinical_relevance":"<p class=\"ai-optimize-9\">El AUS ContiReflex<sup>\u00ae<\/sup> ofrece una opci\u00f3n prometedora para el tratamiento de la incontinencia masculina, con excelentes resultados de seguridad tempranos que respaldan un uso cl\u00ednico m\u00e1s amplio.<\/p>","ce_pdf":null,"ce_logos":null,"ce_featured":true,"ce_keywords":"ContiReflex, esf\u00ednter urinario artificial, incontinencia masculina, AUS, Rigicon, seguridad del dispositivo, resultados quir\u00fargicos, urolog\u00eda"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Resultados de Seguridad ContiReflex\u00ae AUS - Rigicon\u00ae<\/title>\n<meta name=\"description\" content=\"Un an\u00e1lisis multic\u00e9ntrico de 50 pacientes mostr\u00f3 que el AUS ContiReflex\u00ae es seguro y eficaz, sin infecciones, sin erosiones y con una...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/es\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Primeros resultados de seguridad del esf\u00ednter urinario artificial ContiReflex\u00ae para el tratamiento de la incontinencia masculina | Peer-Reviewed Research\" \/>\n<meta property=\"og:description\" content=\"Un an\u00e1lisis multic\u00e9ntrico de 50 pacientes mostr\u00f3 que el AUS ContiReflex\u00ae es seguro y eficaz, sin infecciones, sin erosiones y con una supervivencia del dispositivo del 98% a los 18 meses.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/es\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/04\/header-d.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/clinical-evidence\\\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/clinical-evidence\\\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\\\/\",\"name\":\"Resultados de Seguridad ContiReflex\u00ae AUS - Rigicon\u00ae\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#website\"},\"datePublished\":\"2026-03-12T13:50:04+00:00\",\"description\":\"Un an\u00e1lisis multic\u00e9ntrico de 50 pacientes mostr\u00f3 que el AUS ContiReflex\u00ae es seguro y eficaz, sin infecciones, sin erosiones y con una...\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/clinical-evidence\\\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\\\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/es\\\/clinical-evidence\\\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/clinical-evidence\\\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evidencia Cl\u00ednica\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/clinical-evidence\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Primeros resultados de seguridad del esf\u00ednter urinario artificial ContiReflex\u00ae para el tratamiento de la incontinencia masculina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.net\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\"],\"description\":\"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Resultados de Seguridad ContiReflex\u00ae AUS - Rigicon\u00ae","description":"Un an\u00e1lisis multic\u00e9ntrico de 50 pacientes mostr\u00f3 que el AUS ContiReflex\u00ae es seguro y eficaz, sin infecciones, sin erosiones y con una...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/es\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/","og_locale":"es_ES","og_type":"article","og_title":"Primeros resultados de seguridad del esf\u00ednter urinario artificial ContiReflex\u00ae para el tratamiento de la incontinencia masculina | Peer-Reviewed Research","og_description":"Un an\u00e1lisis multic\u00e9ntrico de 50 pacientes mostr\u00f3 que el AUS ContiReflex\u00ae es seguro y eficaz, sin infecciones, sin erosiones y con una supervivencia del dispositivo del 98% a los 18 meses.","og_url":"https:\/\/www.rigicon.com\/es\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/04\/header-d.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/es\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/","url":"https:\/\/www.rigicon.com\/es\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/","name":"Resultados de Seguridad ContiReflex\u00ae AUS - Rigicon\u00ae","isPartOf":{"@id":"https:\/\/www.rigicon.com\/es\/#website"},"datePublished":"2026-03-12T13:50:04+00:00","description":"Un an\u00e1lisis multic\u00e9ntrico de 50 pacientes mostr\u00f3 que el AUS ContiReflex\u00ae es seguro y eficaz, sin infecciones, sin erosiones y con una...","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/es\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/es\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/es\/clinical-evidence\/first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-es\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.rigicon.com\/es\/"},{"@type":"ListItem","position":2,"name":"Evidencia Cl\u00ednica","item":"https:\/\/www.rigicon.com\/es\/clinical-evidence\/"},{"@type":"ListItem","position":3,"name":"Primeros resultados de seguridad del esf\u00ednter urinario artificial ContiReflex\u00ae para el tratamiento de la incontinencia masculina"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/es\/#website","url":"https:\/\/www.rigicon.com\/es\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/es\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/es\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.rigicon.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.net\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/"],"description":"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/clinical-evidence\/10569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/clinical-evidence"}],"about":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/types\/clinical-evidence"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/media?parent=10569"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/tags?post=10569"},{"taxonomy":"ce_category","embeddable":true,"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/ce_category?post=10569"},{"taxonomy":"ce_product","embeddable":true,"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/ce_product?post=10569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}